Barbados is set to launch a $1.2bn debt-for-social swap by January 1, unlocking more than $320m in savings to fund healthcare programmes and tackle childhood obesity, Finance Minister Ryan Straughn ...

While the adult obesity rate appears to be slowing in the United States, childhood obesity remains historically high, ...

New research presented at the 11th UK Congress on Obesity in Sheffield shows GLP-1 medications are reshaping treatment while behavioural support, stigma reduction and system-level change remain ...

Children older than 10 can be prescribed weight loss jabs and similar drugs if changing lifestyle does not work, the first global guidelines on childhood obesit ...

The global GLP-1 drugs market is entering a new phase of expansion as demand shifts beyond traditional diabetes treatment ...

Learn more Eli Lilly (LLY) said Friday that new data from a phase 3b clinical trial showing broader changes in psoriasis-related and metabolic biomarkers when Taltz and Zepbound were used together, ...

The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.

Hour Detroit Top Doc Suki Singh, M.D. of Henry Ford Health discusses the evolution of the obesity medicine specialty.

Eli Lilly and Company (NYSE: LLY) today announced new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

About 400 million people aged 5 to 19 lived with overweight in 2024, including 170 million with obesity, according to the World Health Organization (WHO). The WHO prioritizes tailored diets, physical ...

New WHO guidelines recommend against obesity drugs and surgery for children under 10, urging focus on healthy diets and ...

Obesity is increasing among India’s poorer households, despite being more common in wealthier urban areas, raising health ...